Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years

Authors :: Marjory Hunt
B Beck
Christian Herzog
Robert van der Ploeg
Christoph Hatz
Gert Frösner
Source :: Clinical and Vaccine Immunology. 18:885-887
Publication Year :: 2011
Publisher :: American Society for Microbiology, 2011.
Abstract: Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.

Full Text Access

Tools